Invesaro

Stocks VIPS Financial statements

Financial statements

Vipshop Holdings Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Vipshop Holdings Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue8,15111,20612,29313,35815,61018,36914,95615,89514,85415,146
Cost of revenue6,1938,7029,81110,38712,34814,74311,82212,27311,36411,644
Gross profit1,9582,5042,4832,9713,2623,6263,1343,6233,4893,502
General and administrative280376389584574657647584547626
Operating expenses1,6202,1722,2412,3782,4732,8952,3412,4532,3582,490
Operating income3904143526868988768991,2821,2571,163
Interest expense12.312.723.212.410.32.273.523.237.912.9
Interest income15.415.535.331.268.8105111110111115
Pre-tax income3843914007101,0761,275
Income tax86.796.282.4141173192255263317257
Net income to minority interests-6.35-8.80.68-4.371.91.851.8911.913.623.9
Net income2933003105779057359131,1431,0601,036
EBITDA4785244648051,0471,0481,0771,4651,4511,382
EPS, basic2.532.552.344.326.705.397.1810.3310.0010.35
EPS, diluted2.432.452.274.256.565.297.1310.169.8310.12
Shares, basic (weighted)116118132134135136127111106100
Shares, diluted (weighted)126126140136138139128113108102

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents5921,5331,3889441,8382,5573,1813,5803,6103,288
Short-term investments3384381,123844231279257826
Receivables33673882518651.37282.3110125127
Inventory7131,0707811,1071,1711,077800795689737
Total current assets2,1003,9833,9743,3084,7775,1544,8915,2905,1795,659
Property, plant and equipment6431,0241,2411,6172,0822,2562,3522,3782,5062,619
Lease right-of-use assets2462421801297859.457
Goodwill52.956.453.4349192.5109106103108
Intangible assets10461.651.448.55150.448.846.944.946.3
Other non-current assets73.656.457.787.315.446.513.320.859.550.2
Total assets3,6145,8386,3366,9789,0339,7749,49310,18610,26611,274
Accounts payable1,2001,7591,6921,9812,3282,0632,1772,4312,0811,793
Accrued liabilities4795448029391,1801,2021,2171,3471,3241,422
Deferred revenue25.131.221417751.370.65864.565.374.5
Short-term debt139195157160310390201329836
Total current liabilities2,1002,9603,7743,4374,0724,0444,1364,3134,1004,416
Lease liabilities20020915012197.181.179.6
Other non-current liabilities18.642.70
Total liabilities2,7823,6483,8333,7824,5304,4664,5534,7554,5744,919
Total debt9.27
Paid-in capital4511,3401,3651,4311,6581,9191,898626673214
Retained earnings5268611,1501,7132,7193,5184,1645,1885,8786,949
Treasury stock-102-303-1,211-511-965-1,126
Other comprehensive income-49.5-3.73-4.49-8.14-9.04-13.9-103-98-111-172
Shareholders' equity8262,1972,5113,1354,3675,1214,7495,2065,4765,864
Minority interests7.15-6.75-7.4260.7136188192225217492
Total equity8332,1902,5033,1964,5045,3084,9405,4315,6926,355
Total liabilities and equity3,6145,8386,3366,9789,0339,7749,49310,18610,26611,274

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2872913105739077369151,1551,0741,060
Depreciation and amortization88111112119149172179183194218
Stock-based compensation68.510397.698.8146158175213211248
Change in receivables-281-408-9.44598151-13.8-14.4-28.1-17.32.15
Change in inventory-98.7-34442.4-377-80.814421184.7129-3.64
Change in payables224494-20.5241
Cash from operations4081518361,7651,8121,0581,5252,0301,2511,066
Capital expenditures-283-338-366-474-343-429-352-305-373-284
Acquisitions-15.3-0.72-395-87.3-23.4-56.2
Purchases of investments-391-470-2,199-1,342-1,623-558-614-1,566
Cash from investing-240-312-974-1,184-1,026-365152-727-488-1,186
Stock issued0.830.920.570.040.1465.900.030.19
Share buybacks-27.9-304-907-719-530-707
Dividends paid-257
Cash from financing-56.61,10285.4-899-3.19-9.23-808-866-681-277
Exchange rate effect-0.93-7.57
Net change in cash113939-26.7-33378068486045090-405
Free cash flow124-1874691,2911,4696301,1731,725878782
Interest paid12.312.723.212.410.32.163.163.737.910.2
Income taxes paid90.9146139118174214238251297349

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $12.38 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin23.1%Gross profit / revenue.
Operating margin7.7%Operating income / revenue.
EBITDA margin9.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin8.4%Pre-tax income / revenue.
Net margin6.8%Net income / revenue.
FCF margin5.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin7.0%Cash from operations / revenue.
Effective tax rate20.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)18.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)9.6%Net income / average total assets.
Return on invested capital (ROIC)41.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue1.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.9%Capital expenditures / revenue.
D&A / revenue1.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y0.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-0.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y0.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y3.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y1.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-7.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y9.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y5.3%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-4.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y8.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-2.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y4.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y2.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y3.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y12.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y9.1%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-14.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-11.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-10.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-10.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-12.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-11.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y7.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y6.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y9.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y4.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-7.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-5.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.28xCurrent assets / current liabilities.
Quick ratio0.96x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.93x(Cash + short-term investments) / current liabilities.
Liabilities / assets43.6%Total liabilities / total assets.
Interest coverage90.4xOperating income / interest expense.
Working capital$1.24BCurrent assets - current liabilities.
Goodwill and intangibles / assets1.4%(Goodwill + intangible assets) / total assets.
Tangible book value$5.71BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.41xRevenue / average total assets.
Fixed asset turnover5.91xRevenue / average property, plant and equipment.
Inventory turnover16.3xCost of revenue / average inventory.
Days inventory22 days365 x average inventory / cost of revenue.
Receivables turnover120xRevenue / average receivables.
Days sales outstanding3 days365 x average receivables / revenue.
Days payables61 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-35 daysDays inventory + days sales outstanding - days payables.
FCF conversion75.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow26.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$10.12Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$10.35Net income per basic share, as reported (split-adjusted).
Revenue per share$147.94Revenue / diluted weighted shares.
FCF per share$7.64Free cash flow / diluted weighted shares.
Operating cash flow per share$10.41Cash from operations / diluted weighted shares.
Book value per share$57.27Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$55.76Tangible book value / shares outstanding.
Cash per share$40.18(Cash + short-term investments) / shares outstanding.
Payout ratio24.8%Dividends paid / net income, when net income is positive.
Dividends / FCF32.8%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF90.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$5.95BShare price x shares outstanding.
Enterprise value$1.83BMarket cap + total debt - cash - short-term investments.
P/E5.74xMarket cap / net income. Only when net income is positive.
P/S0.39xMarket cap / revenue.
P/B1.01xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.04xMarket cap / tangible book value, when positive.
P/FCF7.60xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF5.58xMarket cap / cash from operations, when positive.
EV/Sales0.12xEnterprise value / revenue.
EV/EBIT1.57xEnterprise value / operating income, when both are positive.
EV/EBITDA1.33xEnterprise value / EBITDA, when both are positive.
EV/FCF2.34xEnterprise value / free cash flow, when both are positive.
FCF yield13.2%Free cash flow / market cap.
Earnings yield17.4%Net income / market cap (the inverse of P/E).
Dividend yield4.3%Dividends paid over the period / market cap.
Shareholder yield16.2%(Dividends paid + share buybacks) / market cap.
PEG0.46xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Vipshop Holdings Ltd's revenue in fiscal 2025?

Vipshop Holdings Ltd reported revenue of $15.15B for fiscal 2025, 2% higher than the year before.

Was Vipshop Holdings Ltd profitable in fiscal 2025?

Yes. Net income was $1.04B, a net margin of 6.8%.

How much free cash flow did Vipshop Holdings Ltd generate in fiscal 2025?

Cash from operations of $1.07B minus capital expenditures of $284.0M left free cash flow of $782.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Vipshop Holdings Ltd